Johan Christenson's most recent trade in Fusion Pharmaceuticals Inc was a trade of 13,333,333 Class A Preferred Exchangeable Shares done . Disclosure was reported to the exchange on June 30, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fusion Pharmaceuticals Inc | Johan Christenson | Director | 30 Jun 2020 | 13,333,333 | 0 | - | - | Class A Preferred Exchangeable Shares | ||
Fusion Pharmaceuticals Inc | Johan Christenson | Director | 30 Jun 2020 | 5,712,216 | 0 | - | - | Class B Preferred Exchangeable Shares | ||
Fusion Pharmaceuticals Inc | Johan Christenson | Director | 30 Jun 2020 | 2,497,345 | 2,497,345 | - | - | Common Shares | ||
Fusion Pharmaceuticals Inc | Johan Christenson | Director | 30 Jun 2020 | 1,069,902 | 3,567,247 | - | - | Common Shares | ||
Fusion Pharmaceuticals Inc | Johan Christenson | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 30 Jun 2020 | 240,000 | 3,807,247 | - | 17 | 4,080,000 | Common Shares |
Aprea Therapeutics Inc | Johan Christenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 5,600 | 5,600 | - | - | Stock Option (right to Buy) | |
Fusion Pharmaceuticals Inc | Johan Christenson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jun 2020 | 2,856,108 | 5,712,216 | - | - | Class B Preferred Exchangeable Shares | |
Fusion Pharmaceuticals Inc | Johan Christenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 576,233 | 576,233 | - | - | Warrants to purchase Class B Preferred Exchangeable Shares | |
Fusion Pharmaceuticals Inc | Johan Christenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |